US Stock MarketDetailed Quotes
PZRXQ PhaseRx, Inc.
- 0.000200
- 0.0000000.00%
15min DelayClose Oct 31 16:00 ET
2.34KMarket Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000200Open0.000200Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)11.69MShares0.00030052wk High-0.01P/B1.33KFloat Cap0.00010052wk Low--Dividend TTM6.66MShs Float0.100000Historical High--Div YieldTTM0.00%Amplitude0.000100Historical Low--Avg Price1Lot Size
About PhaseRx, Inc. Company
PhaseRx, Inc. operates as a bio pharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, argininosuccinate lyase deficiency and argininosuccinate synthetase deficiency. The company was founded by Robert W. Overell, Patrick S. Stayton, Allan S. Hoffman, Oliver W. Press and Paul H. Johnson on March 9, 2006 and is headquartered in Seattle, WA.
Company Profile
SymbolPZRXQ
Company NamePhaseRx, Inc.
Listing DateMay 18, 2016
Issue Price5.00
Founded2006
MarketPink Market
Employees21
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address410 West Harrison Street,Suite 300
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98119
Phone1-206-805-6300
Websitehttp://www.phaserx.com
Company Executives
- Name
- Position
- Salary
- Dr. Robert W. Overell,PhD
- Director, President, Secretary, Chief Executive Officer and Principal Accounting Officer
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg